What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Enzyme
- Neuron
His primary areas of study are Internal medicine, Endocrinology, Neuroscience, Neuropeptide and Relaxin-3.
His Internal medicine research integrates issues from Neuron and In situ hybridization.
His Endocrinology research is multidisciplinary, incorporating perspectives in Molecular biology, Hyperesthesia and Myoclonic Jerk.
His Neuropeptide study combines topics in areas such as Amygdala, Nucleus and Anxiety.
Andrew L. Gundlach has researched Relaxin-3 in several fields, including Elevated plus maze, Open field and Anxiolytic.
His Nucleus Incertus study incorporates themes from Forebrain and Dorsal raphe nucleus.
His most cited work include:
- Autoradiographic localization of sigma receptor binding sites in guinea pig and rat central nervous system with (+)3H-3-(3-hydroxyphenyl)-N-(1- propyl)piperidine (352 citations)
- Pharmacological and autoradiographic discrimination of sigma and phencyclidine receptor binding sites in brain with (+)-[3H]SKF 10,047, (+)-[3H]-3-[3-hydroxyphenyl]-N-(1-propyl)piperidine and [3H]-1-[1-(2-thienyl)cyclohexyl]piperidine. (333 citations)
- The galanin peptide family: receptor pharmacology, pleiotropic biological actions, and implications in health and disease. (279 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Internal medicine, Endocrinology, Relaxin-3, Neuroscience and Receptor.
His work investigates the relationship between Internal medicine and topics such as Neuron that intersect with problems in Orexin.
His Endocrinology study combines topics from a wide range of disciplines, such as Neuropeptide, Galanin and In situ hybridization.
His work is dedicated to discovering how Relaxin-3, Tegmentum are connected with GABAergic and other disciplines.
His Neuroscience study frequently draws connections to adjacent fields such as Nucleus Incertus.
His studies in Receptor integrate themes in fields like Endogeny, Stereochemistry and Peptide.
He most often published in these fields:
- Internal medicine (66.37%)
- Endocrinology (65.77%)
- Relaxin-3 (47.92%)
What were the highlights of his more recent work (between 2016-2021)?
- Relaxin-3 (47.92%)
- Neuroscience (42.86%)
- Internal medicine (66.37%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Relaxin-3, Neuroscience, Internal medicine, Endocrinology and Neuropeptide.
His Relaxin-3 study is concerned with the field of Receptor as a whole.
Many of his studies on Neuroscience apply to Nucleus Incertus as well.
His work on Paraventricular nucleus of hypothalamus, Anxiogenic, Lateral hypothalamus and Pars compacta as part of general Internal medicine research is frequently linked to Modulation, bridging the gap between disciplines.
His Endocrinology research includes elements of Neuron and Melanin-concentrating hormone.
His Neuropeptide research includes themes of Oxytocin, Solitary nucleus and Cell biology.
Between 2016 and 2021, his most popular works were:
- Pharmacogenetic stimulation of neuronal activity increases myelination in an axon-specific manner (121 citations)
- Pharmacogenetic stimulation of neuronal activity increases myelination in an axon-specific manner (121 citations)
- The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson’s disease (39 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Enzyme
- Neuron
The scientist’s investigation covers issues in Neuroscience, Relaxin-3, Arousal, Receptor and Internal medicine.
Andrew L. Gundlach interconnects Monoamine neurotransmitter, Orexin and Nucleus Incertus in the investigation of issues within Neuroscience.
The concepts of his Relaxin-3 study are interwoven with issues in Tegmentum and Neuron.
His Tegmentum study integrates concerns from other disciplines, such as Gene knockdown, Agonist, Relaxin, Choline acetyltransferase and MAPK/ERK pathway.
As part of his studies on Internal medicine, he frequently links adjacent subjects like Endocrinology.
The Neuropeptide study combines topics in areas such as Hypothalamus, Oxytocin and Inhibitory postsynaptic potential.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
